| Dr Michelle Marie Barton, MD | |
|
7751 Byron Center Ave Sw Ste C, Byron Center, MI 49315-8001 | |
| (616) 267-7668 | |
| Not Available |
| Full Name | Dr Michelle Marie Barton |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Location | 7751 Byron Center Ave Sw Ste C, Byron Center, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1649765942 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RG0300X | Internal Medicine - Geriatric Medicine | 4301506393 (Michigan) | Secondary |
| 207R00000X | Internal Medicine | 4301506393 (Michigan) | Primary |
| Entity Name | Spectrum Health Primary Care Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235188673 PECOS PAC ID: 4587568647 Enrollment ID: O20031121000091 |
News Archive
Most studies of healthcare for homeless people have been conducted in the United States, where it's not surprising that lack of money and insurance are the main barriers.
Health officials recently held a regional consultation in Kenya to examine mother-to-child HIV transmission services and pediatric HIV/AIDS care in nine Eastern and Southern African countries, IRIN/PlusNews reports.
European drug companies came out ahead of their U.S. counterparts in making medicines available to people in developing countries, but their lead is beginning to shrink, according to the Access to Medicines Index, released on Monday, Reuters reports (Kelland, 6/21).
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.
Newly published data from the International Diabetes Federation (IDF) show that number of people with diabetes continues to grow unchecked. The figures reveal that, if action is not taken to change the path of the epidemic, the numbers of people with diabetes will be close to 440 million by 2030.
› Verified 5 days ago
| Entity Name | Reed City Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1831253798 PECOS PAC ID: 6406740695 Enrollment ID: O20040210000104 |
News Archive
Most studies of healthcare for homeless people have been conducted in the United States, where it's not surprising that lack of money and insurance are the main barriers.
Health officials recently held a regional consultation in Kenya to examine mother-to-child HIV transmission services and pediatric HIV/AIDS care in nine Eastern and Southern African countries, IRIN/PlusNews reports.
European drug companies came out ahead of their U.S. counterparts in making medicines available to people in developing countries, but their lead is beginning to shrink, according to the Access to Medicines Index, released on Monday, Reuters reports (Kelland, 6/21).
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.
Newly published data from the International Diabetes Federation (IDF) show that number of people with diabetes continues to grow unchecked. The figures reveal that, if action is not taken to change the path of the epidemic, the numbers of people with diabetes will be close to 440 million by 2030.
› Verified 5 days ago
| Entity Name | Spectrum Health United |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457304495 PECOS PAC ID: 6305836487 Enrollment ID: O20040612000087 |
News Archive
Most studies of healthcare for homeless people have been conducted in the United States, where it's not surprising that lack of money and insurance are the main barriers.
Health officials recently held a regional consultation in Kenya to examine mother-to-child HIV transmission services and pediatric HIV/AIDS care in nine Eastern and Southern African countries, IRIN/PlusNews reports.
European drug companies came out ahead of their U.S. counterparts in making medicines available to people in developing countries, but their lead is beginning to shrink, according to the Access to Medicines Index, released on Monday, Reuters reports (Kelland, 6/21).
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.
Newly published data from the International Diabetes Federation (IDF) show that number of people with diabetes continues to grow unchecked. The figures reveal that, if action is not taken to change the path of the epidemic, the numbers of people with diabetes will be close to 440 million by 2030.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Michelle Marie Barton, MD 100 Michigan St Ne # Mc845, Grand Rapids, MI 49503-2560 Ph: () - | Dr Michelle Marie Barton, MD 7751 Byron Center Ave Sw Ste C, Byron Center, MI 49315-8001 Ph: (616) 267-7668 |
News Archive
Most studies of healthcare for homeless people have been conducted in the United States, where it's not surprising that lack of money and insurance are the main barriers.
Health officials recently held a regional consultation in Kenya to examine mother-to-child HIV transmission services and pediatric HIV/AIDS care in nine Eastern and Southern African countries, IRIN/PlusNews reports.
European drug companies came out ahead of their U.S. counterparts in making medicines available to people in developing countries, but their lead is beginning to shrink, according to the Access to Medicines Index, released on Monday, Reuters reports (Kelland, 6/21).
Octapharma AG, one of the largest global manufacturers of human proteins, today announced the enrolment of the first two patients in its GAM-27 Phase II/III clinical trial for the treatment of relapsing multiple sclerosis. Through intravenous administration of immunoglobulin (Octagam 5%), the study seeks to support the overall clinical benefit of a lower annualised relapse rate in patients where first-line treatment is not suitable.
Newly published data from the International Diabetes Federation (IDF) show that number of people with diabetes continues to grow unchecked. The figures reveal that, if action is not taken to change the path of the epidemic, the numbers of people with diabetes will be close to 440 million by 2030.
› Verified 5 days ago
Iris Boettcher, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7751 Byron Center Ave Sw, Suite C, Byron Center, MI 49315 Phone: 616-776-7430 | |
Dr. Stacy Walton Goldsholl, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 2745 Railside Ct Sw, Byron Center, MI 49315 Phone: 910-297-4552 | |
Mary Beth Tupper, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7751 Byron Center Ave Sw, Suite C, Byron Center, MI 49315 Phone: 616-267-7668 | |
Dr. Guibin Li, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7751 Byron Center Ave Sw Ste C, Byron Center, MI 49315 Phone: 616-267-7668 | |
Carlos Orval Weiss, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 7751 Byron Center Ave Sw Ste C, Byron Center, MI 49315 Phone: 616-267-7668 | |
Angela R Andrews, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2373 64th St Sw, Suite 1300, Byron Center, MI 49315 Phone: 616-685-1350 Fax: 616-261-7191 |